Cancer Research UK logo.
SearchDonate
  • Search

A study looking at whether aspirin and ticagrelor affect blood clotting and how cancer spreads (TICONC)

Overview

Cancer types:

All cancer types, Bowel (colorectal) cancer, Breast cancer, Colon cancer, Rectal cancer, Secondary cancers

Status:

Results

Phase:

Phase 1/2

Details

This study was done to find out what effect aspirin and ticagrelor have on blood clotting cells and how cancer spreads.

The study was open for people to join between 2015 and 2018. The team published the results in 2020.

Recruitment start: 2 November 2015

Recruitment end: 31 July 2018

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr David Adlam

Supported by

AstraZeneca

ECMC

Hope Against Cancer

NIHR Clinical Research Network: Cancer

University of Leicester

Last reviewed: 7 July 2022

CRUK internal database number: 13458

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.